This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Emergent BioSolutions Inc (EBS)

NYSE: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 312.80M 280.50M 179.34M 141.67M
Receivables 127.34M 60.19M 66.24M 96.04M
Inventories 76.94M 65.67M 14.64M 15.16M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 538.61M 432.18M 273.12M 263.35M
Property, Plant & Equipment, Gross 431.38M 393.41M 321.61M 284.71M
Accumulated Depreciation & Depletion 99.53M 79.43M 57.37M 42.94M
Property, Plant & Equipment, Net 331.86M 313.98M 264.24M 241.76M
Intangibles 99.88M 136.14M 71.95M 0.00
Other Non-Current Assets 7.06M 8.22M 3.37M 42.53M
Total Non-Current Assets 504.98M 513.09M 353.51M 300.88M
Liabilities & Shareholder Equity
Total Assets 1.04B 945.26M 626.63M 564.23M
Accounts Payable 45.97M 40.93M 27.52M 31.30M
Short Term Debt 0.00 0.00 0.00 4.47M
Other Current Liabilities 4.79M 8.73M 1.34M 115.00K
Total Current Liabilities 99.61M 92.94M 56.65M 61.91M
Long Term Debt 253.00M 251.00M 62.00M 58.30M
Deferred Income Taxes 0.00 0.00 1.42M 0.00
Other Non-Current Liabilities 30.96M 48.12M 17.39M 1.89M
Minority Interest 0.00 0.00 -876.00K -5.38M
Total Non-Current Liabilities 283.96M 299.12M 80.36M 60.97M
Total Liabilities 383.57M 392.06M 137.01M 122.87M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 660.02M 553.20M 489.62M 441.36M
Common Par 40.00K 38.00K 37.00K 36.00K
Additional Paid In Capital 317.97M 274.22M 247.64M 230.96M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 351.14M 288.27M 251.53M 220.39M
Treasury Stock -6.42M -6.32M -6.12M -5.91M
Other Equity Adjustments -2.71M -3.01M -3.46M -4.13M
Total Capitalization 913.02M 804.20M 551.62M 499.66M
Total Equity 660.02M 553.20M 489.62M 441.36M
Total Liabilities & Stock Equity 1.04B 945.26M 626.63M 564.23M
Total Common Shares Outstanding 39.41M 37.71M 36.62M 35.87M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 422.83K 420.19K 412.95K 403.16K
Basic Weighted Shares Outstanding 38.60M 37.34M 36.20M 36.08M
Diluted Weighted Shares Outstanding 47.26M 45.80M 36.75M 36.42M
Number of Employees 1292 1280 1353 877
Number of Part-Time Employees 0 0 0 0
EBS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

EBS Emergent BioSolutions Inc

Chart of EBS

Analysts Ratings for EBS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET EBS ANALYST REPORT

EBS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs